<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36917411</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2193-8237</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Pain and therapy</Title><ISOAbbreviation>Pain Ther</ISOAbbreviation></Journal><ArticleTitle>COVID-19-Related Burning Eye Syndrome and Burning Mouth Syndrome: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>621</StartPage><EndPage>630</EndPage><MedlinePgn>621-630</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40122-023-00492-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous research highlights burning eye syndrome (BES) and burning mouth syndrome (BMS) as chronic complications of COVID-19 infection. The aim of this systematic review and meta-analysis is to establish the prevalence of COVID-19-related BES and COVID-19-related BMS and describe their phenomenology.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="METHODS">A literature search in the PubMed database was performed, and seven papers (five on BES and two on BMS) were eligible to be included in this systematic review and meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The pooled prevalence of COVID-19-related BES was 9.9% (95% CI 3.4-25.4%). The frequency of COVID-19-related BMS is only reported in isolated cases and ranges from 4% in mild-to-moderate cases to 15% in severe, hospitalized cases, with female patients being mostly affected. COVID-19 severity is a potential risk factor for both BES and BMS. Neither syndrome occurs in isolation. COVID-19-related BES usually appears within the first week post-infection, persisting up to 9&#xa0;weeks later. COVID-19-related BMS occurs during and after initial infection, and may also persist as a chronic disease.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Both BES and BMS are neuropathic COVID-19 infection complications, still under-studied and under-investigated, despite the fact that both are prevalent. Both COVID-19-related BES and COVID-19-related BMS could potentially be initial long COVID syndrome manifestations, and further research should be carried out in this field.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Laura D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Medical School, University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zis</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8567-3092</Identifier><AffiliationInfo><Affiliation>Medical School, University of Sheffield, Sheffield, UK. takiszis@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical School, University of Cyprus, Nicosia, Cyprus. takiszis@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Second Department of Neurology, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece. takiszis@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Pain Ther</MedlineTA><NlmUniqueID>101634491</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Burning eyes</Keyword><Keyword MajorTopicYN="N">Burning mouth</Keyword><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>The authors have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36917411</ArticleId><ArticleId IdType="pmc">PMC10012304</ArticleId><ArticleId IdType="doi">10.1007/s40122-023-00492-3</ArticleId><ArticleId IdType="pii">10.1007/s40122-023-00492-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Attal N, Martinez V, Bouhassira D. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep. 2021;6(1):e884. doi: 10.1097/PR9.0000000000000884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000884</ArticleId><ArticleId IdType="pmc">PMC7850724</ArticleId><ArticleId IdType="pubmed">33537521</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkana Y, Belkin M. Laser eye injuries. Surv Ophthalmol. 2000;44(6):459&#x2013;478. doi: 10.1016/S0039-6257(00)00112-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0039-6257(00)00112-0</ArticleId><ArticleId IdType="pubmed">10906379</ArticleId></ArticleIdList></Reference><Reference><Citation>Belmonte C, Acosta MC, Merayo-Lloves J, Gallar J. What causes eye pain? Curr Ophthalmol Rep. 2015;3(2):111&#x2013;121. doi: 10.1007/s40135-015-0073-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40135-015-0073-9</ArticleId><ArticleId IdType="pmc">PMC4432221</ArticleId><ArticleId IdType="pubmed">26000205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender SD. Burning mouth syndrome. Dent Clin North Am. 2018;62(4):585&#x2013;596. doi: 10.1016/j.cden.2018.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cden.2018.05.006</ArticleId><ArticleId IdType="pubmed">30189984</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdy GJ, Hedqvist B. Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management. Acta Ophthalmologica Scandinavica-Supplementum. 2000;230:32&#x2013;37. doi: 10.1034/j.1600-0420.2000.078s230032.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0420.2000.078s230032.x</ArticleId><ArticleId IdType="pubmed">11057347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365&#x2013;388. doi: 10.1080/10408363.2020.1783198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1783198</ArticleId><ArticleId IdType="pubmed">32645276</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauw DJ, H&#xe4;user W, Cohen SP, Fitzcharles MA. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020;161(8):1694. doi: 10.1097/j.pain.0000000000001950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001950</ArticleId><ArticleId IdType="pmc">PMC7302093</ArticleId><ArticleId IdType="pubmed">32701829</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies KS. Formulating the evidence-based practice question: a review of the frameworks. Evid Based Libr Inf Pract. 2011;6(2):75&#x2013;80. doi: 10.18438/B8WS5N.</Citation><ArticleIdList><ArticleId IdType="doi">10.18438/B8WS5N</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugan C, Popescu BO, Parlatescu I, Dobre M, Milanesi E, Popa C. Clinical and psychological impact of SARS-CoV-2 infection in burning-mouth syndrome patients: a comparative study. Romanian J Oral Rehabilit. 2022;14:15&#x2013;25.</Citation></Reference><Reference><Citation>Feng Y, Armenti ST, Albin OR, Mian SI. Novel case of an adult with toxic shock syndrome following COVID-19 infection. Am J Ophthalmol Case Rep. 2020;20:100843. doi: 10.1016/j.ajoc.2020.100843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajoc.2020.100843</ArticleId><ArticleId IdType="pmc">PMC7387279</ArticleId><ArticleId IdType="pubmed">32835131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdeghini C, Mirabelli L, Bianco E, Hari S, Maddalone M. Oral manifestations in hospitalized COVID patients. World J Dent. 2022;13(5):434&#x2013;440. doi: 10.5005/jp-journals-10015-2082.</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10015-2082</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox PC. Autoimmune diseases and Sj&#xf6;gren&#x2019;s syndrome: an autoimmune exocrinopathy. Ann NY Acad Sci. 2007;1098(1):15&#x2013;21. doi: 10.1196/annals.1384.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1384.003</ArticleId><ArticleId IdType="pubmed">17332090</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomazzi S, Urits I, Hoyt B, Hubble A, Cornett EM, Gress K, Charipova K, Berger AA, Kassem H, Kaye AD, Viswanath O. Comprehensive review and update of burning eye syndrome. J Patient-Centered Res Rev. 2021;8(3):255. doi: 10.17294/2330-0698.1813.</Citation><ArticleIdList><ArticleId IdType="doi">10.17294/2330-0698.1813</ArticleId><ArticleId IdType="pmc">PMC8297487</ArticleId><ArticleId IdType="pubmed">34322578</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934&#x2013;939. doi: 10.1016/j.jclinepi.2011.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.11.014</ArticleId><ArticleId IdType="pubmed">22742910</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;&#xe4;skel&#xe4;inen SK. Is burning mouth syndrome a neuropathic pain condition? Pain. 2018;159(3):610&#x2013;613. doi: 10.1097/j.pain.0000000000001090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001090</ArticleId><ArticleId IdType="pubmed">29257770</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;&#xe4;skel&#xe4;inen SK, Woda A. Burning mouth syndrome. Cephalalgia. 2017;37(7):627&#x2013;647. doi: 10.1177/0333102417694883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102417694883</ArticleId><ArticleId IdType="pubmed">28569120</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi D, Gyanpuri V, Pathak A, Chaurasia RN, Mishra VN, Kumar A, Singh VK, Dhiman NR. Neuropathic pain associated with COVID-19: a systematic review of case reports. Curr Pain Headache Rep. 2022;26:1&#x2013;9. doi: 10.1007/s11916-022-01065-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01065-3</ArticleId><ArticleId IdType="pmc">PMC9214475</ArticleId><ArticleId IdType="pubmed">35731363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalangara JP, Galor A, Levitt RC, Felix ER, Alegret R, Sarantopoulos CD. Burning eye syndrome: do neuropathic pain mechanisms underlie chronic dry eye? Pain Med. 2016;17(4):746&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6281056</ArticleId><ArticleId IdType="pubmed">26814296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kommoss FK, Schwab C, Tavernar L, Schreck J, Wagner WL, Merle U, Jonigk D, Schirmacher P, Longerich T. The pathology of severe COVID-19-related lung damage: mechanistic and therapeutic implications. Dtsch Arztebl Int. 2020;117(29&#x2013;30):500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588618</ArticleId><ArticleId IdType="pubmed">32865490</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):1&#x2013;13. doi: 10.1186/1471-2105-9-559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauria G, Majorana A, Borgna M, Lombardi R, Penza P, Padovani A, Sapelli P. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain. 2005;115(3):332&#x2013;337. doi: 10.1016/j.pain.2005.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2005.03.028</ArticleId><ArticleId IdType="pubmed">15911160</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite VF, Rampim DB, Jorge VC, de Lima MDCC, Cezarino LG, da Rocha CN, Esper RB. Prevent Senior COVID-19. Rehabilitation study persistent symptoms and disability after COVID-19 hospitalization: data from a comprehensive telerehabilitation program. Arch Phys Med Rehabil. 2021;102(7):1308&#x2013;1316. doi: 10.1016/j.apmr.2021.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7943375</ArticleId><ArticleId IdType="pubmed">33711279</ArticleId></ArticleIdList></Reference><Reference><Citation>Liampas A, Velidakis N, Georgiou T, Vadalouca A, Varrassi G, Hadjigeorgiou GM, Tsivgoulis G, Zis P. Prevalence and management challenges in central post-stroke neuropathic pain: a systematic review and meta-analysis. Adv Ther. 2020;37(7):3278&#x2013;3291. doi: 10.1007/s12325-020-01388-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-020-01388-w</ArticleId><ArticleId IdType="pmc">PMC7467424</ArticleId><ArticleId IdType="pubmed">32451951</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri A, Oliverio GW, Mancuso G, Giuffrida A, Guarneri C, Venanzi Rullo E, Nunnari G, Aragona P. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep. 2020;10(1):1&#x2013;7. doi: 10.1038/s41598-020-77194-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77194-9</ArticleId><ArticleId IdType="pmc">PMC7677531</ArticleId><ArticleId IdType="pubmed">33214658</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthyam AK, Reddy MP, Kulkarni S, Srilatha A, Sahithi K, Satyanarayana D. Oral manifestations in COVID-19 patients: an observational study. J Fam Med Prim Care. 2022;11(3):1000. doi: 10.4103/jfmpc.jfmpc_1264_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_1264_21</ArticleId><ArticleId IdType="pmc">PMC9051711</ArticleId><ArticleId IdType="pubmed">35495817</ArticleId></ArticleIdList></Reference><Reference><Citation>Nied&#x17a;wied&#x17a; A, Kawa M, Pius-Sadowska E, Kuligowska A, Ziontkowska A, Wrza&#x142;ek D, Parczewski M, Safranow K, Koz&#x142;owski K, Machali&#x144;ski B, Machali&#x144;ska A. Evaluating ocular symptoms and tear film cytokine profiles in symptomatic COVID-19 patients. J Clin Med. 2022;11(9):2647. doi: 10.3390/jcm11092647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11092647</ArticleId><ArticleId IdType="pmc">PMC9105717</ArticleId><ArticleId IdType="pubmed">35566776</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel SJ, Lundy DC. Ocular manifestations of autoimmune disease. Am Fam Physician. 2002;66(6):991.</Citation><ArticleIdList><ArticleId IdType="pubmed">12358224</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12&#x2013;A13. doi: 10.7326/ACPJC-1995-123-3-A12.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/ACPJC-1995-123-3-A12</ArticleId><ArticleId IdType="pubmed">7582737</ArticleId></ArticleIdList></Reference><Reference><Citation>Rokohl AC, Loreck N, Matos PAW, Zwingelberg S, Augustin M, Dewald F, Grajewski RS, Klein F, Lehmann C, Heindl LM. More than loss of taste and smell: burning watering eyes in coronavirus disease 2019. Clin Microbiol Infect. 2020;26(11):1560&#x2013;e5. doi: 10.1016/j.cmi.2020.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.08.018</ArticleId><ArticleId IdType="pmc">PMC7442009</ArticleId><ArticleId IdType="pubmed">32835793</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 2015;6(3):432&#x2013;444. doi: 10.4239/wjd.v6.i3.432.</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v6.i3.432</ArticleId><ArticleId IdType="pmc">PMC4398900</ArticleId><ArticleId IdType="pubmed">25897354</ArticleId></ArticleIdList></Reference><Reference><Citation>Seghal G, Bal P, Bal B, Chopra R. Pattern of ocular manifestations and the prevalence of severe acute respiratory syndrome coronavirus-2 in tears of hospitalized coronavirus disease 2019 patients. Taiwan J Ophthalmol. 2021;11(4):380. doi: 10.4103/tjo.tjo_40_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/tjo.tjo_40_21</ArticleId><ArticleId IdType="pmc">PMC8757522</ArticleId><ArticleId IdType="pubmed">35070667</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh N, Al Mahdi H, Pai A, Pathare A, Abujaber AA, Dsliva A, Al-Jabry M, Subramanian K, Thomas S, Mohmed AS, Anjum S. Ocular manifestations of COVID-19: facts and figures from a tertiary care center. Ann Med. 2022;54(1):310&#x2013;313. doi: 10.1080/07853890.2022.2029554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2029554</ArticleId><ArticleId IdType="pmc">PMC8786237</ArticleId><ArticleId IdType="pubmed">35060821</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, Sandroni P, Benarroch EE, Berini SE, Cutsforth-Gregory JK, Coon EA. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31(3):385&#x2013;394. doi: 10.1007/s10286-021-00803-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinjari B, D&#x2019;Ardes D, Santilli M, Rexhepi I, D&#x2019;Addazio G, Di Carlo P, Chiacchiaretta P, Caputi S, Cipollone F. SARS-CoV-2 and oral manifestation: an observational, human study. J Clin Med. 2020;9(10):3218. doi: 10.3390/jcm9103218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9103218</ArticleId><ArticleId IdType="pmc">PMC7600761</ArticleId><ArticleId IdType="pubmed">33036482</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrypnikova T, Skrypnykov P, Shynkevych V. Long term oral symptoms systematization in patients who underwent COVID-19: case series research. J Int Dent Med Res. 2022;15:1133&#x2013;1142.</Citation></Reference><Reference><Citation>Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol. 2013;32(1):19&#x2013;41. doi: 10.3109/08830185.2012.748052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2012.748052</ArticleId><ArticleId IdType="pmc">PMC3587314</ArticleId><ArticleId IdType="pubmed">23360156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, Ouoba S, Akita T, Tanimine N, Ohdan H, Kubo T, Nagasawa A. Long COVID occurrence in COVID-19 survivors. Sci Rep. 2022;12(1):1&#x2013;11. doi: 10.1038/s41598-022-10051-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10051-z</ArticleId><ArticleId IdType="pmc">PMC8996498</ArticleId><ArticleId IdType="pubmed">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallejo-Garcia JL, Balia L, Raimondi R, Rustioni G, Camesasca FI, Borgia A, Fossati G, Confalonieri F, Legrottaglie EF, Casari E, Sandri MT. Conjunctivitis as a sign of persistent SARS-COV-2 infection? An observational study and report of late symptoms. Eur J Ophthalmol. 2022;32(2):830&#x2013;835. doi: 10.1177/11206721211056594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11206721211056594</ArticleId><ArticleId IdType="pmc">PMC8935141</ArticleId><ArticleId IdType="pubmed">34761693</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarroel-Dorrego M, Chac&#xf3;n L, Rosas R, Barrios V, Pern&#xed;a Y, V&#xe9;lez H. [Translated article] Oral findings in patients with COVID-19. Actas dermo-sifiliograficas. 2022;113(2):T183&#x2013;T186. doi: 10.1016/j.ad.2022.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ad.2022.02.002</ArticleId><ArticleId IdType="pmc">PMC8444350</ArticleId><ArticleId IdType="pubmed">34545255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, Arendt-Nielsen L, Torres-Macho J, Plaza-Manzano G. Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. 2022;14(12):2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>